摘要
背景:罕见的疾病往往是严重的,危及生命和虚弱的疾病。如今,近8000种罕见疾病,估计有3.5亿人受到全球这些情况的影响。不幸的是,罕见的疾病是相当复杂和慢性的,只有少部分这些疾病可以被相关地诊断和治疗,并且通常需要终身治疗。 目的:探讨罕见疾病问题,描述其分类,讨论当前的治疗和管理,并对未来的研究进行深入研究。方法:本研究采用的方法包括PubMed,Springer和Web of Science等世界公认数据库的文献综述,特别是2000年至2015年期间。另外还提供了一种比较和评估相关来源的结果的方法用来。 结果:研究结果证实,罕见疾病由于合并症而难以诊断。一旦诊断出来,他们就需要昂贵和长期的治疗,这引起了各国政府的关注。 结论:因此,要在稀有疾病的空间进行更多的研究,以扩大对他们的了解,诊断和治疗,从而对医护人员进行更好的培训,最终使病人受益。
关键词: 罕见疾病,分类,描述,治疗,管理,孤儿疾病
Current Medicinal Chemistry
Title:Global View on Rare Diseases: A Mini Review
Volume: 24 Issue: 29
关键词: 罕见疾病,分类,描述,治疗,管理,孤儿疾病
摘要: Background: Rare diseases are often serious, life-threatening and debilitating group of disorders. Nowadays, there are approximately 8,000 rare diseases and it is estimated that 350 million people are affected by these conditions worldwide. Unfortunately, rare diseases are quite complex and chronic, only a small number of these diseases can be relevantly diagnosed and treated, and lifelong treatment is often required.
Objective: The purpose of this mini review is to explore the issue of rare diseases, describe their classification, discuss the current treatment and management and set future research in this field. Methods: The methods applied in this review include literature review of the world's acknowledged databases such as PubMed, Springer and Web of Science, especially in the period of 2000 to 2015. Furthermore, a method of comparison and evaluation of the findings from the relevant sources is used.
Results: The findings confirm that rare diseases are still quite difficult to diagnose due to their comorbidities. Once they are diagnosed, they demand costly and long-term treatment, which raises concerns of national governments.
Conclusion: Therefore more research should be done in the space of rare diseases in order to broaden knowledge about them, their diagnosis and treatment, which will then lead to better training of medical staff, and ultimately will benefit the patients.
Export Options
About this article
Cite this article as:
Global View on Rare Diseases: A Mini Review, Current Medicinal Chemistry 2017; 24 (29) . https://dx.doi.org/10.2174/0929867324666170511111803
DOI https://dx.doi.org/10.2174/0929867324666170511111803 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial (Thematic Issue: The Acute Management of Pediatric Heart Failure)
Current Cardiology Reviews Alzheimer Disease and Diabetes Mellitus: Do They have Anything in Common?
Current Alzheimer Research Mesenchymal Stromal Cell Therapy for Cardio Renal Disorders
Current Pharmaceutical Design Roles of IL-6-gp130 Signaling in Vascular Inflammation
Current Cardiology Reviews The Role of Fibrate Treatment in Dyslipidemia: An Overview
Current Pharmaceutical Design Hypertension in Type 2 Diabetes Mellitus: Do We Need to Redefine the Role of Sulfonylureas?
Recent Advances in Cardiovascular Drug Discovery (Discontinued) A Survey on Left Ventricle Segmentation Techniques in Cardiac Short Axis MRI
Current Medical Imaging Cellular Cardiomyoplasty and Cardiac Regeneration
Current Cardiology Reviews Targeting the Fatty Acid Transport Proteins (FATP) to Understand the Mechanisms Linking Fatty Acid Transport to Metabolism
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Inhibition of Histone Deacetylases: A Pharmacological Approach to the Treatment of Non-Cancer Disorders
Current Topics in Medicinal Chemistry Dendritic Cell Homeostasis in the Regulation of Self-Reactivity
Current Pharmaceutical Design Gemcitabine-Related Atrial Fibrillation: A Case Report and Review of the Literature
Current Drug Safety Cardiovascular Disease Burden and Risk Factors Before and After Kidney Transplant
Cardiovascular & Hematological Disorders-Drug Targets Adrenomedullin: Roles for Structure and Function in Cardiac or Vascular Tissues
Current Hypertension Reviews Endothelial Dysfunction in Morbid Obesity
Current Pharmaceutical Design Aldosteronism in Heart Failure: A Proinflammatory / Fibrogenic Cardiac Phenotype. Search for Biomarkers and Potential Drug Targets
Current Drug Targets New Approaches for the Treatment of Chagas Disease
Current Drug Targets Secretory Leukocyte Protease Inhibitor: More than Just A Protease Inhibitor
Current Immunology Reviews (Discontinued) Lipoprotein Subfractions, Uric Acid and Cardiovascular Risk in End-Stage Renal Disease (ESRD) Patients
Current Vascular Pharmacology Tissue Engineering Techniques in Cardiac Repair and Disease Modelling
Current Pharmaceutical Design